Key Ingredients
Brivaracetam IP 50 mg: A next-generation antiepileptic agent with high affinity for SV2A protein, enabling rapid onset of action and reliable seizure suppression.
Benefits
Effective Control of Partial-Onset Seizures: Reduces seizure frequency and improves neurological stability.
Rapid Brain Penetration: Ensures fast therapeutic action for better seizure management.
Fewer Drug Interactions: Safe for use with most other antiepileptic medicines.
Flexible Therapy Option: Recommended for monotherapy or as add-on therapy depending on patient needs.
Usage Instructions
Take orally, with or without food, as prescribed by the physician. Do not discontinue suddenly without medical supervision.
Side Effects
May include dizziness, fatigue, nausea, sleepiness, or mood changes. Seek medical help if severe symptoms occur.
General Information
- Form: Tablet
- Strength: 50 mg
- Composition: Brivaracetam IP
- Indications: Partial-Onset Seizures (Monotherapy / Adjunctive Therapy)
- Route: Oral
- Dosage: As directed by the physician
- Storage: Store below 30°C; protect from light and moisture
- Manufacturer: Globus Labs
- Country of Origin: India
Globus Labs brings you WHO-GMP–certified, high-quality Brivaracetam IP sourced from reputed pharmaceutical manufacturers. Brivadey-50 is formulated to deliver safe, potent, and clinically trusted support.
